Celldex Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 6.10 M | $157.83 M | 0.00% | 9.19% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 5.80 M | $150.05 M | 10.85% | 8.74% |
| BLACKROCK, INC. | 11/12/2025 | 5.51 M | $142.44 M | -0.79% | 8.29% |
| FMR LLC | 11/13/2025 | 4.96 M | $128.37 M | -8.77% | 7.47% |
| VANGUARD GROUP INC | 11/07/2025 | 3.95 M | $102.31 M | -0.06% | 5.96% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 3.89 M | $100.74 M | 38.98% | 5.87% |
| BELLEVUE GROUP AG | 11/14/2025 | 3.56 M | $92.04 M | 7.56% | 5.36% |
| COMMODORE CAPITAL LP | 11/14/2025 | 3.03 M | $78.34 M | -12.22% | 4.56% |
| STATE STREET CORP | 11/14/2025 | 2.84 M | $73.53 M | 18.15% | 4.28% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 2.38 M | $61.64 M | -37.59% | 3.59% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 2.00 M | $51.74 M | 0.00% | 3.01% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 1.86 M | $48.10 M | 37.08% | 2.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.65 M | $42.62 M | -1.54% | 2.48% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 1.30 M | $33.64 M | 5.86% | 1.96% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.21 M | $31.35 M | -6.79% | 1.83% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 1.21 M | $31.17 M | -31.14% | 1.82% |
| NOVO HOLDINGS A/S | 11/14/2025 | 1.20 M | $31.04 M | 0.00% | 1.81% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 1.15 M | $29.85 M | 37.58% | 1.74% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.03 M | $26.63 M | 41.51% | 1.55% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 975.20 K | $25.23 M | 104.35% | 1.47% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2025 | 927.16 K | $23.99 M | 12.76% | 1.40% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 815.56 K | $21.10 M | 4.56% | 1.23% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 721.54 K | $18.67 M | -11.21% | 1.09% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 665.37 K | $17.21 M | 0.00% | 1.00% |
| NORTHERN TRUST CORP | 11/14/2025 | 595.39 K | $15.40 M | 3.39% | 0.90% |
| BRAIDWELL LP | 11/14/2025 | 591.69 K | $15.31 M | 100.00% | 0.89% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 553.87 K | $14.33 M | 0.14% | 0.83% |
| SEGALL BRYANT & HAMILL, LLC | 11/12/2025 | 528.60 K | $13.67 M | 36.28% | 0.80% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2025 | 497.27 K | $12.86 M | 0.00% | 0.75% |
| UBS GROUP AG | 11/13/2025 | 416.45 K | $10.77 M | -50.50% | 0.63% |
| TSP CAPITAL MANAGEMENT GROUP, LLC | 10/22/2025 | 375.93 K | $9.73 M | 1.21% | 0.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 348.92 K | $9.03 M | 75.83% | 0.53% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 338.81 K | $8.77 M | 22.68% | 0.51% |
| REDMILE GROUP, LLC | 11/14/2025 | 327.01 K | $8.46 M | -4.67% | 0.49% |
| CITADEL ADVISORS LLC | 11/14/2025 | 319.33 K | $8.26 M | -15.69% | 0.48% |
| MORGAN STANLEY | 11/14/2025 | 311.92 K | $8.07 M | -52.85% | 0.47% |
| TFG ASSET MANAGEMENT GP LTD | 11/14/2025 | 303.60 K | $7.85 M | -3.97% | 0.46% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 300.00 K | $7.76 M | 100.00% | 0.45% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 257.33 K | $6.66 M | -60.14% | 0.39% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 257.08 K | $6.65 M | 78.67% | 0.39% |
| NUVEEN, LLC | 11/12/2025 | 249.20 K | $6.45 M | -6.16% | 0.38% |
| BARCLAYS PLC | 11/12/2025 | 244.83 K | $6.33 M | -6.81% | 0.37% |
| CI PRIVATE WEALTH, LLC | 11/14/2025 | 239.61 K | $6.21 M | 18.78% | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 207.76 K | $5.37 M | -50.48% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 205.69 K | $5.32 M | 5.97% | 0.31% |
| WOODLINE PARTNERS LP | 11/14/2025 | 199.29 K | $5.16 M | -86.72% | 0.30% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 194.59 K | $5.03 M | 7.28% | 0.29% |
| JPMORGAN CHASE & CO | 11/26/2025 | 184.78 K | $4.78 M | -20.98% | 0.28% |
| MIRADOR CAPITAL PARTNERS LP | 10/07/2025 | 165.92 K | $4.29 M | 4.54% | 0.25% |
| PROPEL BIO MANAGEMENT, LLC | 11/12/2025 | 155.00 K | $4.01 M | 100.00% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Celldex Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 235 institutional investors and hedge funds held shares of Celldex Therapeutics, Inc.. The most heavily invested institutionals were:
Kynam Capital Management, LP: 6.1 M
WELLINGTON MANAGEMENT GROUP LLP: 5.8 M
BlackRock, Inc.: 5.51 M
FMR LLC: 4.96 M
VANGUARD GROUP INC: 3.95 M
Point72 Asset Management, L.P.: 3.89 M
106.53% of Celldex Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 78.97 M shares in the last 24 months. This purchase volume represents approximately $2.09 B in transactions.